Recon: Novartis to buy Tourmaline for $1.4B; Trump could offer carve-outs for pharma in future trade pacts
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States